Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies.

Saved in:
Bibliographic Details
Title: Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies.
Authors: Dash S; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Translational Medicine Doctoral School, Centre of Postgraduate Medical Education, Warsaw, Poland., Firmanty P; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Translational Medicine Doctoral School, Centre of Postgraduate Medical Education, Warsaw, Poland., Chomczyk M; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Mohanty V; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ma W; Sanford Stem Cell Institute, Department of Medicine and Moores Cancer Center, University of California, San Diego, San Diego, CA, United States., Baran N; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Department of Hematology and Central Hematology Laboratory, InselSpital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Internal Medicine, Sanford School of Medicine, The University of South Dakota, Sioux Falls, SD, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Feb 27; Vol. 17, pp. 1749965. Date of Electronic Publication: 2026 Feb 27 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first